Folkvaljon, F., Gertz, M., Gillmore, J. D., Khella, S., Masri, A., Maurer, M. S., Cruz, M. W., Wixner, J., Chen, J., Reicher, B., Kwoh, J., Yarlas, A., & Berk, J. L. (2024). Estimating Meaningful Differences in Measures of Neuropathic Impairment, Health‐Related Quality of Life, and Nutritional Status in Patients With Hereditary Transthyretin Amyloidosis. Muscle & Nerve, 71(1), 96–107. Portico. https://doi.org/10.1002/mus.28299

Berry, J. D., Paganoni, S., Harms, M. B., Shneider, N., Andrews, J., Miller, T. M., Babu, S., Sherman, A. V., Harris, B. T., Provenzano, F. A., Phatnani, H. P., Shefner, J., Garret, M. A., Ladha, S. S., Tsou, A. Y., Mohan, P., Igne, C., & Bowser, R. (2024). Access for ALL in ALS: A large‐scale, inclusive, collaborative consortium to unlock the molecular and genetic mechanisms of amyotrophic lateral sclerosis. Muscle & Nerve, 70(6), 1140–1150. Portico. https://doi.org/10.1002/mus.28244

Karam, C., Mauermann, M. L., Gonzalez‐Duarte, A., Kaku, M. C., Ajroud‐Driss, S., Brannagan, T. H., & Polydefkis, M. (2024). Diagnosis and treatment of hereditary transthyretin amyloidosis with polyneuropathy in the United States: Recommendations from a panel of experts. Muscle & Nerve, 69(3), 273–287. Portico. https://doi.org/10.1002/mus.28026

Tavee, J., Brannagan, T. H., Lenihan, M. W., Muppidi, S., Kellermeyer, L., & D Donofrio, P. (2023). Updated consensus statement: Intravenous immunoglobulin in the treatment of neuromuscular disorders report of the AANEM ad hoc committee. Muscle & Nerve, 68(4), 356–374. Portico. https://doi.org/10.1002/mus.27922

Crawford, T. O., Swoboda, K. J., De Vivo, D. C., Bertini, E., Hwu, W., Finkel, R. S., Kirschner, J., Kuntz, N. L., Nazario, A. N., Parsons, J. A., Pechmann, A., Ryan, M. M., Butterfield, R. J., Topaloglu, H., Ben‐Omran, T., Sansone, V. A., Jong, Y., Shu, F., … Zhu, C. (2023). Continued benefit of nusinersen initiated in the presymptomatic stage of spinal muscular atrophy: 5‐year update of theNURTUREstudy. Muscle & Nerve, 68(2), 157–170. Portico. https://doi.org/10.1002/mus.27853

Cheng, R., Feng, J., Goodwin, A. M., Uher, D., Rao, A. K., McDermott, M. P., De Vivo, D. C., Ewing Garber, C., & Montes, J. (2022). Perceived exertion is not a substitute for fatiguability in spinal muscular atrophy. Muscle & Nerve, 68(1), 81–84. Portico. https://doi.org/10.1002/mus.27765

Lee, I., Stingone, J. A., Chan, R. B., & Mitsumoto, H. (2023). Utilizing machine learning and lipidomics to distinguish primary lateral sclerosis from amyotrophic lateral sclerosis. Muscle & Nerve, 67(4), 306–310. Portico. https://doi.org/10.1002/mus.27797

Sadjadi, R., Kelly, K., Glanzman, A. M., Montes, J., Linsenmayer, M., Tellez, M., Bartlett, A., Heintzman, S., Kolb, S. J., Arnold, W. D., & El‐Sheikh, B. (2023). Psychometric evaluation of modified spinal muscular atrophy functional rating scale (SMAFRS) in adult patients using Rasch analysis. Muscle & Nerve, 67(3), 239–243. Portico. https://doi.org/10.1002/mus.27785

Cook, M., Pasnoor, M., Ajroud‐Driss, S., Brannagan, T. H., Dimachkie, M. M., & Allen, J. A. (2022). CIDP prognosis in patients with IVIG treatment‐related fluctuations. Muscle & Nerve, 67(1), 69–73. Portico. https://doi.org/10.1002/mus.27746

De León, A. M., Aban, I., McPherson, T., Granit, V., Benatar, M., Cutter, G., & Lee, I. (2022). Impact of the COVID‐19 pandemic on patients with myasthenia gravis: A survey of the Myasthenia Gravis Foundation of America MG patient registry. Muscle & Nerve, 67(1), 25–32. Portico. https://doi.org/10.1002/mus.27743

Thakore, N. J., Lapin, B. R., Mitsumoto, H., & Pooled Resource Open‐Access ALS Clinical Trials Consortium. (2022). Early initiation of riluzole may improve absolute survival in amyotrophic lateral sclerosis. Muscle & Nerve, 66(6), 702–708. Portico. https://doi.org/10.1002/mus.27724

Darras, B. T., Guye, S., Hoffart, J., Schneider, S., Gravestock, I., Gorni, K., Fuerst‐Recktenwald, S., Scalco, R. S., Finkel, R. S., & De Vivo, D. C. (2022). Distribution of weight, stature, and growth status in children and adolescents with spinal muscular atrophy: An observational retrospective study in the United States. Muscle & Nerve, 66(1), 84–90. Portico. https://doi.org/10.1002/mus.27556

Miller, R. G., Zhang, R., Bracci, P. M., Azhir, A., Barohn, R., Bedlack, R., Benatar, M., Berry, J. D., Cudkowicz, M., Kasarskis, E. J., Mitsumoto, H., Manousakis, G., Walk, D., Oskarsson, B., Shefner, J., & McGrath, M. S. (2022). Phase 2B randomized controlled trial of NP001 in amyotrophic lateral sclerosis: Pre‐specified and post hoc analyses. Muscle & Nerve, 66(1), 39–49. Portico. https://doi.org/10.1002/mus.27511